![Kavita Aggarwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kavita Aggarwal
Technik-/Wissenschafts-/F&E-Leiter bei
VERONA PHARMA PLC
Profil
Kavita Aggarwal currently works at Verona Pharma Plc, as Senior Vice President-Medical Affairs from 2023.
Dr. Aggarwal also formerly worked at BioCryst Pharmaceuticals, Inc., as VP-Global Commercial Pipeline Strategy and Dova Pharmaceuticals, Inc., as Vice President-Medical Affairs.
Dr. Aggarwal received her undergraduate degree from North Carolina State University and doctorate degree from the University of North Carolina at Chapel Hill.
Aktive Positionen von Kavita Aggarwal
| Unternehmen | Position | Beginn |
|---|---|---|
| VERONA PHARMA PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
Ehemalige bekannte Positionen von Kavita Aggarwal
| Unternehmen | Position | Ende |
|---|---|---|
| DOVA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| BIOCRYST PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Kavita Aggarwal
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
24
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
 Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
